Authors: Vrana, JA Decker, RH Johnson, CR Wang, Z Jarvis, WD Richon, VM Ehinger, M Fisher, PB Grant, S

Citation: Ja. Vrana et al., Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-X-L, c-Jun, and p21(CIP1), but independent of p53, ONCOGENE, 18(50), 1999, pp. 7016-7025

Authors: Jarvis, WD Grant, S

Citation: Wd. Jarvis et S. Grant, Protein kinase C targeting in antineoplastic treatment strategies, INV NEW DR, 17(3), 1999, pp. 227-240

Authors: Tombes, RM Mikkelsen, RB Jarvis, WD Grant, S

Citation: Rm. Tombes et al., Downregulation of delta CaM kinase II in human tumor cells, BBA-MOL CEL, 1452(1), 1999, pp. 1-11

Authors: Jarvis, WD Johnson, CR Fornari, FA Park, JS Dent, P Grant, S

Citation: Wd. Jarvis et al., Evidence that the apoptotic actions of etoposide are independent of c-Jun/activating protein-1-mediated transregulation, J PHARM EXP, 290(3), 1999, pp. 1384-1392

Authors: Schwarz, YX Yang, MY Qin, DH Wu, JH Jarvis, WD Grant, S Burton, GF Szakal, AK Tew, JG

Citation: Yx. Schwarz et al., Follicular dendritic cells protect malignant B cells from apoptosis induced by anti-Fas and antineoplastic agents, J IMMUNOL, 163(12), 1999, pp. 6442-6447

Authors: Dent, P Jarvis, WD Birrer, MJ Fisher, PB Schmidt-Ullrich, RK Grant, S

Citation: P. Dent et al., The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity, LEUKEMIA, 12(12), 1998, pp. 1843-1850